Efficacy and Safety of a Preoperative Aerobic Exercise Program in Patients With Gastrointestinal Cancer.

Sponsor
Instituto Nacional de Cancerologia, Columbia (Other)
Overall Status
Unknown status
CT.gov ID
NCT03423056
Collaborator
Universidad Nacional de Colombia (Other)
40
1
1
33
1.2

Study Details

Study Description

Brief Summary

Patients with gastrointestinal cancer often experience physical deconditioning; this could lead to an increased risk of complications, especially when they require major abdominal surgical procedures.

It has been suggested that physical training in the preoperative period could improve their condition, reducing the risk of complications. Although this topic has been investigated, it has not been established yet the best short preoperative aerobic exercise program to enhance the aerobic capacity in patients with gastrointestinal cancer who are going to be to surgical primary management, and consequently, to help patients dealing with the physiological stress involved in a surgical intervention.

Main objective:

To determine the efficacy and safety of a 4 weeks preoperative exercise program in patients with gastrointestinal cancer scheduled for primary surgery.

Materials and methods:

This is a Phase II single arm clinical trial that will include patients between 45 and 70 years, with confirmed gastrointestinal cancer (gastric, hepatic, colon or rectal cancer), without electrocardiographic abnormalities, and scheduled for primary surgery in 4 weeks or more since recruitment

All the enrolled patients will receive a basal aerobic capacity assessment with the 6-minute walk test. Then, two physical therapist will prescribe them a supervised and individualized aerobic training program in 3 sessions per week during 4 weeks. Each session will last 50 minutes and will increase the heart rate target weekly (from 50% to 70% of the maximum heart rate). The aerobic exercise will be carried on a treadmill or in a stationary bicycle.

The post intervention aerobic capacity will be measured at week 3 and 4 with the 6-minute walk test. The main efficacy outcome will be peak oxygen consumption (VO2 peak) and the safety outcomes will be exercise-related adverse events and the program adherence.

This protocol was approved by the Instituto Nacional de Cancerología's Ethical Board

Condition or Disease Intervention/Treatment Phase
  • Other: Preoperative exercise program
N/A

Detailed Description

Gastrointestinal - origin cancer is one of the most frequent causes of cancer worldwide ; the primary surgical management is the standard treatment, however, the postoperative complications rate could be up to 35% . Patients with gastrointestinal - origin cancer often experience physical deconditioning; this could lead to an increased risk of complications, especially when they require major abdominal procedures.

It has been suggested that physical training in the preoperative period could improve their condition, reducing the risk of complications. Although this topic has been investigated, it has not been established yet the best short preoperative aerobic exercise program to enhance the aerobic capacity in patients with gastrointestinal cancer who are going to be to surgical primary management, and consequently, to help patients dealing with the physiological stress involved in a surgical intervention.

Main objective:

To determine the efficacy and safety of a 4 weeks preoperative exercise program in patients with gastrointestinal cancer scheduled for primary surgery.

Materials and methods:

This is a Phase II single arm clinical trial that will include patients between 45 and 70 years, with confirmed gastrointestinal cancer (gastric, liver, colon or rectal cancer), scheduled for surgery in 4 weeks or more since recruitment and without electrocardiographic abnormalities.

The patients will be selected from the gastrointestinal unit surgical schedule. The eligible patients will be invited to participate and after their agreement to participate and to do the informed consent process, they will be scheduled to the basal assessment. This aerobic capacity assessment will be done with the 6-minute walk test.

After the basal measurement, two physical therapists will prescribe an individualized aerobic training program in 3 sessions per week during 4 weeks. Each session will last 50 minutes and will be programmed as follows:

  • Week 1: heart rate target: 50% of maximum heart rate

  • Week 2: heart rate target: 60% of maximum heart rate

  • Week 3: heart rate target: 70% of maximum heart rate

  • Week 4: heart rate target: 60% of maximum heart rate

The aerobic exercise will be carried on a treadmill or in a stationary bicycle, according to the patient's preferences and will be supervised by a physical therapist.

The post intervention aerobic capacity will be measured at week 3 and 4 with the 6-minute walk test. The main efficacy outcome will be peak oxygen consumption (VO2 peak) and the safety outcomes will be exercise-related adverse events and the program adherence.

This protocol was approved by the Instituto Nacional de Cancerología's Ethical Board.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
The individualized aerobic training program will be developed according to Karvonem's equation . It will programmed in 3 sessions/week (not in row) during 4 weeks Each 50-minutes session will be organized in three phases: warm up, central and back to calm. The heart rate target will be prescribed as follows: Week 1: heart rate target: 50% of maximum heart rate Week 2: heart rate target: 60% of maximum heart rate Week 3: heart rate target: 70% of maximum heart rate Week 4: heart rate target: 60% of maximum heart rate The aerobic exercise will be carried on a treadmill or in a stationary bicycle, according to the patient's preferences and will be supervised by a physical therapist. The post intervention aerobic capacity will be measured at week 3 and 4 with the 6-minute walk test.The individualized aerobic training program will be developed according to Karvonem's equation . It will programmed in 3 sessions/week (not in row) during 4 weeksEach 50-minutes session will be organized in three phases: warm up, central and back to calm. The heart rate target will be prescribed as follows:Week 1: heart rate target: 50% of maximum heart rate Week 2: heart rate target: 60% of maximum heart rate Week 3: heart rate target: 70% of maximum heart rate Week 4: heart rate target: 60% of maximum heart rate The aerobic exercise will be carried on a treadmill or in a stationary bicycle, according to the patient's preferences and will be supervised by a physical therapist. The post intervention aerobic capacity will be measured at week 3 and 4 with the 6-minute walk test.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Efficacy and Safety of a Preoperative Aerobic Exercise Program in Patients With Gastrointestinal Cancer. A Phase II Clinical Trial
Actual Study Start Date :
Apr 1, 2017
Anticipated Primary Completion Date :
May 1, 2019
Anticipated Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Preoperative exercise program

The individualized aerobic training program will be developed according to Karvonem's equation . It will programmed in 3 sessions/week (not in row) during 4 weeks. Each 50-minutes session will be organized in three phases: warm up, central and back to calm. The heart rate target will be prescribed as follows: Week 1: heart rate target: 50% of maximum heart rate Week 2: heart rate target: 60% of maximum heart rate Week 3: heart rate target: 70% of maximum heart rate Week 4: heart rate target: 60% of maximum heart rate The aerobic exercise will be carried on a treadmill or in a stationary bicycle, according to the patient's preferences and will be supervised by a physical therapist.

Other: Preoperative exercise program
Individualized aerobic training program developed by physical therapist using Karvonem's equation . It will programmed in 3 sessions/week (not in row) during 4 weeks. Each 50-minutes session will be organized in three phases: warm up, central and back to calm. The heart rate target will be prescribed between 50 to 70% of the maximum heart rate and will be carried on a treadmill or in a stationary bicycle.
Other Names:
  • Preoperative aerobic exercise short program
  • Outcome Measures

    Primary Outcome Measures

    1. Peak oxygen comsumption [4 weeks after the exercise program beginning]

      peak oxygen consumption measured in ml/kg/min using the American College of Sports Medicine's equation

    Secondary Outcome Measures

    1. exercise-related adverse events [3 and 4 weeks after the exercise program beginning]

      any unexpected reaction secondary to the exercise program. This could be mild (nausea, fall, joint pain, tendinitis) or severe (syncope, fracture, myocardial infarction).

    2. program adherence [3 weeks after the exercise program beginning.]

      frequency of patients who will complete at least the 3 week program.

    3. Peak oxygen comsumption - 3 weeks [3 weeks after the exercise program beginning]

      peak oxygen consumption measured in ml/kg/min using the American College of Sports

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    • 45 to 70 years

    • Confirmed diagnosis of gastric, hepatic, colon or rectal cancer.

    • Live in Bogota for at least 3 months

    • Hemoglobin concentration superior to 10g/dL

    • Primary surgery date scheduled in the next 4 weeks or more since eligibility assessment

    • ECOG score 0 or 1

    Exclusion criteria:
    • Behavior or cognitive impairment

    • musculoskeletal impairment

    • any exercise contraindication (fracture or sprains in the last 2 months, severe osteoarthritis, tendinitis)

    • Uncontrolled metabolically comorbidities (diabetes, hypertension, hyperlipidemia)

    • Presence of obstructive or restrictive pulmonary disease

    • Enrolled in another supervised exercise program

    • Major electrocardiographic abnormalities.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Instituto Nacional de Cancerología Bogota Cundinamarca Colombia 0000

    Sponsors and Collaborators

    • Instituto Nacional de Cancerologia, Columbia
    • Universidad Nacional de Colombia

    Investigators

    • Principal Investigator: Oscar A Guevara, MD MSc, Instituto Nacional de Cancerología

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Instituto Nacional de Cancerologia, Columbia
    ClinicalTrials.gov Identifier:
    NCT03423056
    Other Study ID Numbers:
    • C41030617-091
    First Posted:
    Feb 6, 2018
    Last Update Posted:
    Jan 24, 2019
    Last Verified:
    Jan 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Instituto Nacional de Cancerologia, Columbia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 24, 2019